INS and Alzheimer disease: Furthermore, it was demonstrated that the treatment with intranasal insulin improves learning and memory in individuals with mild cognitive impairment (MCI) and AD, suggesting the involvement of dysfunctional insulin signaling as a key player in the pathogenic mechanism of AD progression.